180 related articles for article (PubMed ID: 34311077)
1. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3.
Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM
Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077
[TBL] [Abstract][Full Text] [Related]
2. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.
Yu M; Lee SM; Lee H; Amouzegar A; Nakao T; Chen Y; Dana R
Am J Pathol; 2020 Jan; 190(1):125-133. PubMed ID: 31669306
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Lee HS; Chauhan SK; Okanobo A; Nallasamy N; Dana R
Cornea; 2011 Dec; 30(12):1465-72. PubMed ID: 21993466
[TBL] [Abstract][Full Text] [Related]
5. Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling.
Liu L; Dana R; Yin J
FASEB J; 2020 May; 34(5):6229-6243. PubMed ID: 32162744
[TBL] [Abstract][Full Text] [Related]
6. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Goyal S; Chauhan SK; Dana R
Arch Ophthalmol; 2012 Jan; 130(1):84-9. PubMed ID: 21911653
[TBL] [Abstract][Full Text] [Related]
7. Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor.
Taketani Y; Marmalidou A; Dohlman TH; Singh RB; Amouzegar A; Chauhan SK; Chen Y; Dana R
Am J Pathol; 2020 Sep; 190(9):1859-1866. PubMed ID: 32473919
[TBL] [Abstract][Full Text] [Related]
8. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
9. Corneal lymphangiogenesis as a potential target in dry eye disease - a systematic review.
Chennakesavalu M; Somala SRR; Dommaraju SR; Peesapati MP; Guo K; Rosenblatt MI; Chang JH; Azar DT
Surv Ophthalmol; 2021; 66(6):960-976. PubMed ID: 33811911
[TBL] [Abstract][Full Text] [Related]
10. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
11. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.
Kubo H; Cao R; Brakenhielm E; Mäkinen T; Cao Y; Alitalo K
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8868-73. PubMed ID: 12070340
[TBL] [Abstract][Full Text] [Related]
12. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
[TBL] [Abstract][Full Text] [Related]
13. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI
Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
16. Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease.
Ji YW; Lee JL; Kang HG; Gu N; Byun H; Yeo A; Noh H; Kim S; Choi EY; Song JS; Lee HK
Ocul Surf; 2018 Jul; 16(3):306-313. PubMed ID: 29601983
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
18. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
19. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.
Han L; Su W; Huang J; Zhou J; Qiu S; Liang D
PLoS One; 2014; 9(9):e108931. PubMed ID: 25268699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
